Business Wire

Amylgen and Neuron-Experts Announce Strategic Partnership


Amylgen and Neuron-Experts, two leading preclinical CROs specialized in CNS pathologies, today announced an exclusive and strategic partnership that combines their respective in-vivo and in-vitro expertise to provide a new offering for a rapid efficacy assessment of compounds in neurodegenerative diseases.

Under this agreement, Amylgen and Neuron-Experts, who both serve biotechnology, pharmaceutical and nutraceutical companies as part of their preclinical development for CNS pathologies, will jointly provide customers with a new, rapid and comprehensive offering to evaluate on in-vitro and in-vivo models the efficacy of compounds in neurodegenerative diseases. This new preclinical offering will provide a first efficacy proof of concept to select the most effective compound among several leads. Subsequent studies will be possible to further investigate the therapeutical benefit, the elucidation of action mecanism, the therapeutical strategy...

Helping our clients achieve their strategic preclinical objectives is our core focus and we continue to build out our suite of services and partnerships to support that mission,” said Vanessa Villard, CEO, Amylgen. “In Neuron-Experts, we chose a partner who not only provides best-in-class expertise in CNS in-vitro testing, but also shares our deep commitment to ensuring mutual clients have access to the most comprehensive and effective solutions to evaluate the clinical potential of their compounds.

As a trusted partner to biotech companies for their preclinical development in neurodegenerative diseases, we believe in the great value to offer a rapid efficacy assessment of new compounds combining in-vitro and in-vivo testing as a primary proof of concept. We are honored to be partnered with Amylgen, a respected and innovative in-vivo preclinical CRO, to launch this new offering and together we look forward to delivering significant value to our clients,” said Remy Steinschneider, CEO, Neuron-Experts.

Amylgen will market this joint offering, that will be launched as a first step to assess the efficacy of compounds on Alzheimer’s Disease. The offer will be rapidly extended to other neurodegenerative diseases.

About Neuron-Experts
Neuron Experts is a Contract Research Organization (CRO) specialized in the in-vitro study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modelling neurodegenerative diseases and neuronal impairment-induced skin disorders.

About Amylgen
Amylgen is a privately held preclinical CRO offering a unique combination of validated in-vivo rodent models and a full range testing allowing fast and predictive screening of the effects of drugs and nutraceuticals on brain health. Thanks to background in the Industry, we guarantee satisfaction and provide our services with nonconditional high quality standards and with full awareness of time sensitive deadlines in the frame of critical phases of your product development.

Contact information

Laura Ceolin -
Tel: +33 4 67 63 99 87

Tel: +33 4 86 01 11 95

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Science, Data, and Facts Should Unite Decision-Making, Says PMI CEO in Speech at Concordia Summit24.9.2020 22:20:00 EESTPress release

André Calantzopoulos, CEO of Philip Morris International (PMI) (NYSE: PM), today delivered high-level remarks at the 2020 Concordia Annual Summit. Calantzopoulos discussed the impact that uncertainty, polarization, hyperpartisanship, and ideology are having on international efforts to overcome pressing global issues. He called for science to be protected from politicization and highlighted the importance of developing open dialogues based on factual scientific objectivity. Calantzopoulos shared PMI’s belief that with the right regulatory encouragement and support from civil society, cigarette sales can end within 10 to 15 years in many countries. The Concordia Annual Summit, which coincides with the United Nations General Assembly (UNGA) meeting, convenes the world’s most prominent business, government, and nonprofit leaders to foster dialogue and enable effective partnerships for positive social impact. Excerpts of the remarks by André Calantzopoulos follow: “Reflecting on the state o

Swiss Medical Group Holding Acquires CoreMedica Europe24.9.2020 18:54:00 EESTPress release

Swiss Medical Group (SMG) Holding Luxembourg S.A., leading the development of STARKS Age-Management in Europe and Asia, announced today the acquisition of CoreMedica Europe, to expand in Europe and the rest of the world. CoreMedica Europe recently made the headlines in Switzerland for combining a COVID-19 Screening Test and Immunity profile with its existing home self-collection kit that allows customers to collect a few drops of blood and send them by mail to CoreMedica Europe’s accredited laboratory in Geneva to screen the anti-SARS-COV-2 IgG antibody and assess any previous infection to SARS-COV-2, the virus responsible for COVID disease, and analyze a set of 5 key biomarkers known to support the immune system (vitamin D, zinc, magnesium, copper, selenium) so as to receive personalized actionable recommendations to help patients build up their natural defenses against the effects of a next potential viral infection. “In this epidemic and containment context the essential objective

Esri and AfroChampions Launch Partnership to Promote GIS in Africa24.9.2020 16:52:00 EESTPress release

Esri, the global leader in location intelligence, today announced a joint initiative with AfroChampions, a Pan-African nonprofit that aims to promote policies that foster private-public collaboration for Africa's economic transformation. The goal of the initiative is to engage leaders in business, governments, the African Union, and other regional economic communities through dialogue and potential partnership building in applying geospatial technology and solutions. This new partnership with AfroChampions seeks to contribute to sustainable economic development in Africa and promote the benefits of a shared geospatial infrastructure throughout the continent. As a majority of Africans still live in rural areas, geographic information system (GIS) technology can create new opportunities for growth, especially in critical fields such as health and telemedicine, land management, agriculture, and mobility. The powerful mapping and data analytics that GIS provides forms a foundation for some

DXC Technology Announces Leadership Appointments to Support the “new DXC"24.9.2020 16:20:00 EESTPress release

DXC Technology (NYSE:DXC) today presented its latest leadership appointments further strengthening the DXC leadership team, the majority being new to DXC within the last year. This team is bringing the “new DXC,” which is focused on its customers and its people, to the market as it executes the company’s transformation journey. DXC Customer Portfolio Leadership Over the past year, CEO Mike Salvino has recruited new IT services industry leaders who bring formidable experience delivering for customers, inspiring people, and running and growing businesses. DXC announces the following appointments and changes to the team that will run DXC’s business and lead execution of the DXC transformation journey: Americas will be led by Jim Brady and David Swift . Jim joined DXC in June 2020 from Accumen, where he was the COO and previously worked at Accenture and Honeywell. David Swift joined DXC in November 2019 from Accolade where he was Chief Service Officer and previously worked at Aon Hewitt an

Statement on One-Year Anniversary of Women’s Entrepreneurship Accelerator24.9.2020 16:07:00 EESTPress release

Please find the statement below from Women’s Entrepreneurship Accelerator leadership regarding the one-year anniversary of the ground-breaking initiative. This press release features multimedia. View the full release here: Anita Bhatia, Deputy Executive Director, UN Women One year ago, we committed to educating and empowering ten million women entrepreneurs over the next ten years through the Women’s Entrepreneurship Accelerator (WEA). We began to lay the groundwork for a systemic transformation to break down the barriers keeping women from achieving financial independence and contributing to a better future for themselves and their communities. Today, in our unprecedented reality, women find themselves at history’s crossroads. They are disproportionately harmed by the economic devastation wrought by COVID-19 while simultaneously holding the keys to recovery. Women make up 39% of global employment but have accounted for 54% of o

Airship Acquires Conversational Commerce Pioneer ReplyBuy to Accelerate Expansion Into Mobile Commerce24.9.2020 16:00:00 EESTPress release

Customer engagement company Airship today announced that it has acquired ReplyBuy, a company that pioneered fully integrated solutions for payments over SMS. This move extends Airship’s platform beyond customer engagement to directly enable commerce, as well as power one-to-one customer conversations via two-way SMS. In addition, Airship plans to extend ReplyBuy’s technology to provide turnkey commerce and payments solutions across more marketing channels, messaging platforms and industry verticals. The acquisition will provide companies of all sizes a single platform to create, manage and optimize cross-channel customer interactions and drive greater revenue more quickly. Airship’s real-time mobile data, predictive AI and unified approach to customer journeys ensures relevant messaging at the optimal time on customers’ preferred channels across app and web notifications, SMS, email, mobile wallet and more. Subsequent digital actions customers take, now including purchases and conversa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom